These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38685562)
1. High-dimensional mass cytometry identified circulating natural killer T-cell subsets associated with protection from cytomegalovirus infection in kidney transplant recipients. Donadeu L; Jouve T; Bin S; Hartzell S; Crespo E; Torija A; Jarque M; Kervella D; Zúñiga J; Zhang W; Sun Z; Verlato A; Martínez-Gallo M; Font-Miñarro C; Meneghini M; Toapanta N; Torres IB; Sellarés J; Perelló M; Kaminski H; Couzi L; Loupy A; La Manna G; Moreso F; Cravedi P; Bestard O Kidney Int; 2024 Sep; 106(3):482-495. PubMed ID: 38685562 [TBL] [Abstract][Full Text] [Related]
2. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients]. Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495 [TBL] [Abstract][Full Text] [Related]
3. Dynamics of cytomegalovirus-specific T-cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study. Jacobs SE; Ibrahim U; Vega AB; Lagdameo J; Callahan J; Govindarajulu U; Gitman M; Levine JE; Rana M; Keyzner A Transpl Infect Dis; 2024 Jun; 26(3):e14290. PubMed ID: 38708941 [TBL] [Abstract][Full Text] [Related]
4. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients. San-Juan R; Navarro D; García-Reyne A; Montejo M; Muñoz P; Carratala J; Len O; Fortun J; Muñoz-Cobo B; Gimenez E; Eworo A; Sabe N; Meije Y; Martín-Davila P; Andres A; Delgado J; Jimenez C; Amat P; Fernández-Ruiz M; López-Medrano F; Lumbreras C; Aguado JM; Transpl Infect Dis; 2015 Oct; 17(5):637-46. PubMed ID: 26134282 [TBL] [Abstract][Full Text] [Related]
5. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment. Fernández-Ruiz M; Giménez E; Vinuesa V; Ruiz-Merlo T; Parra P; Amat P; Montejo M; Paez-Vega A; Cantisán S; Torre-Cisneros J; Fortún J; Andrés A; San Juan R; López-Medrano F; Navarro D; Aguado JM; Clin Microbiol Infect; 2019 Mar; 25(3):381.e1-381.e10. PubMed ID: 29803844 [TBL] [Abstract][Full Text] [Related]
6. Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study. Martín-Gandul C; Pérez-Romero P; Mena-Romo D; Molina-Ortega A; González-Roncero FM; Suñer M; Bernal G; Cordero E; Transpl Infect Dis; 2018 Jun; 20(3):e12883. PubMed ID: 29570917 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients. Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473 [TBL] [Abstract][Full Text] [Related]
8. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia. Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229 [TBL] [Abstract][Full Text] [Related]
9. CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients. Makwana N; Foley B; Fernandez S; Lee S; Irish A; Pircher H; Price P Eur J Immunol; 2017 Aug; 47(8):1324-1334. PubMed ID: 28586095 [TBL] [Abstract][Full Text] [Related]
10. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation. Davis ZB; Cooley SA; Cichocki F; Felices M; Wangen R; Luo X; DeFor TE; Bryceson YT; Diamond DJ; Brunstein C; Blazar BR; Wagner JE; Weisdorf DJ; Horowitz A; Guethlein LA; Parham P; Verneris MR; Miller JS Biol Blood Marrow Transplant; 2015 Sep; 21(9):1653-62. PubMed ID: 26055301 [TBL] [Abstract][Full Text] [Related]
11. Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients. Fernández-Ruiz M; Silva JT; López-Medrano F; Allende LM; San Juan R; Cambra F; Justo I; Paz-Artal E; Jiménez C; Aguado JM Transpl Infect Dis; 2016 Aug; 18(4):552-65. PubMed ID: 27260953 [TBL] [Abstract][Full Text] [Related]
12. Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity. Bengnér M; Béziat V; Ernerudh J; Nilsson BO; Löfgren S; Wikby A; Malmberg KJ; Strindhall J Age (Dordr); 2014 Apr; 36(2):571-82. PubMed ID: 24065293 [TBL] [Abstract][Full Text] [Related]
13. The adaptive and innate immune systems coordinate for successful control of CMV infection. Schaenman JM Kidney Int; 2024 Sep; 106(3):364-366. PubMed ID: 39174198 [TBL] [Abstract][Full Text] [Related]
14. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56 Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS Front Immunol; 2020; 11():1231. PubMed ID: 32625211 [TBL] [Abstract][Full Text] [Related]
15. Pre-Transplant Frequencies of FoxP3 Mooslechner AA; Schuller M; Pfeifer V; Klötzer KA; Prietl B; Kirsch AH; Stiegler P; Sucher R; Sourij H; Rosenkranz AR; Eller K Transpl Int; 2024; 37():12963. PubMed ID: 38868358 [TBL] [Abstract][Full Text] [Related]
16. CD4(+) T cell levels are decreased during active CMV infection in kidney transplant recipients. Essa S; Pacsa AS; Raghupathy R; Al-Attiyah R; El-Shazly A; Said T FEMS Immunol Med Microbiol; 2002 Sep; 34(1):17-22. PubMed ID: 12208602 [TBL] [Abstract][Full Text] [Related]
18. Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients. Banas B; Böger CA; Lückhoff G; Krüger B; Barabas S; Batzilla J; Schemmerer M; Köstler J; Bendfeldt H; Rascle A; Wagner R; Deml L; Leicht J; Krämer BK BMC Immunol; 2017 Mar; 18(1):15. PubMed ID: 28270092 [TBL] [Abstract][Full Text] [Related]
19. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation. Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275 [TBL] [Abstract][Full Text] [Related]
20. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection. Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]